DK1541676T3 - Mod prothrombin-fragment F1 2 rettede abtistoffer, deres fremstilling og anvendelse - Google Patents
Mod prothrombin-fragment F1 2 rettede abtistoffer, deres fremstilling og anvendelseInfo
- Publication number
- DK1541676T3 DK1541676T3 DK04022637T DK04022637T DK1541676T3 DK 1541676 T3 DK1541676 T3 DK 1541676T3 DK 04022637 T DK04022637 T DK 04022637T DK 04022637 T DK04022637 T DK 04022637T DK 1541676 T3 DK1541676 T3 DK 1541676T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibody
- isolated
- amino acids
- prothrombin
- reagent
- Prior art date
Links
- 102100027378 Prothrombin Human genes 0.000 title abstract 3
- 108010094028 Prothrombin Proteins 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 title abstract 3
- 229940039716 prothrombin Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000003146 anticoagulant agent Substances 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000004408 hybridoma Anatomy 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 239000012491 analyte Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000002537 thrombolytic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10354403A DE10354403A1 (de) | 2003-11-20 | 2003-11-20 | Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1541676T3 true DK1541676T3 (da) | 2009-04-14 |
Family
ID=34485233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04022637T DK1541676T3 (da) | 2003-11-20 | 2004-09-23 | Mod prothrombin-fragment F1 2 rettede abtistoffer, deres fremstilling og anvendelse |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7795403B2 (ja) |
| EP (1) | EP1541676B1 (ja) |
| JP (1) | JP5588585B2 (ja) |
| AT (1) | ATE418604T1 (ja) |
| CA (1) | CA2488127C (ja) |
| DE (2) | DE10354403A1 (ja) |
| DK (1) | DK1541676T3 (ja) |
| ES (1) | ES2316911T3 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008049601A1 (de) | 2008-09-30 | 2010-04-01 | Siemens Healthcare Diagnostics Products Gmbh | Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay |
| JP6032470B2 (ja) * | 2012-08-09 | 2016-11-30 | 富士レビオ株式会社 | Ｐｉｖｋａ−ｉｉ測定方法、測定試薬及び測定キット |
| AU2020259982A1 (en) | 2019-04-17 | 2021-10-28 | Novo Nordisk A/S | Bispecific antibodies |
| EP4239338A1 (de) | 2022-03-03 | 2023-09-06 | Siemens Healthcare Diagnostics Products GmbH | Globaltest zur feststellung des status des blutgerinnungssystems |
| EP4325224A1 (de) | 2022-08-18 | 2024-02-21 | Siemens Healthcare Diagnostics Products GmbH | Thrombozytenaktivierungstest zur diagnose einer heparin-induzierten thrombozytopenie |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| DE3727610A1 (de) * | 1987-08-19 | 1989-03-02 | Behringwerke Ag | Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung |
| US6541275B1 (en) * | 1988-02-03 | 2003-04-01 | Dade Behring Inc. | Immunoassay for F1.2 prothrombin fragment |
| IE903930A1 (en) | 1989-11-06 | 1991-05-08 | Akzo Nv | Immunoassays for and monoclonal antibodies to prothrombin¹activation peptides and their degradation products |
| KR20000018933A (ko) * | 1998-09-07 | 2000-04-06 | 김승수 | 내피세포 성장억제 활성을 가지는 사람 프로트롬빈 크링글단백질 및 이를 암호하는 유전자 |
| ATE449107T1 (de) * | 2002-01-25 | 2009-12-15 | Univ Aberdeen | Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung |
| JP2007527503A (ja) * | 2003-06-17 | 2007-09-27 | プロノタ・エヌブイ | ペプチドコンボ及びそれらの使用 |
-
2003
- 2003-11-20 DE DE10354403A patent/DE10354403A1/de not_active Withdrawn
-
2004
- 2004-09-23 AT AT04022637T patent/ATE418604T1/de active
- 2004-09-23 DE DE502004008729T patent/DE502004008729D1/de active Active
- 2004-09-23 DK DK04022637T patent/DK1541676T3/da active
- 2004-09-23 ES ES04022637T patent/ES2316911T3/es active Active
- 2004-09-23 EP EP04022637A patent/EP1541676B1/de active Active
- 2004-11-19 US US10/992,351 patent/US7795403B2/en active Active
- 2004-11-19 CA CA2488127A patent/CA2488127C/en active Active
- 2004-11-19 JP JP2004335578A patent/JP5588585B2/ja not_active Expired - Fee Related
-
2009
- 2009-11-16 US US12/591,303 patent/US8063180B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5588585B2 (ja) | 2014-09-10 |
| JP2005154440A (ja) | 2005-06-16 |
| US20050113562A1 (en) | 2005-05-26 |
| DE502004008729D1 (de) | 2009-02-05 |
| CA2488127A1 (en) | 2005-05-20 |
| US7795403B2 (en) | 2010-09-14 |
| US8063180B2 (en) | 2011-11-22 |
| ATE418604T1 (de) | 2009-01-15 |
| EP1541676B1 (de) | 2008-12-24 |
| CA2488127C (en) | 2012-10-23 |
| DE10354403A1 (de) | 2005-06-23 |
| EP1541676A1 (de) | 2005-06-15 |
| ES2316911T3 (es) | 2009-04-16 |
| US20100158932A1 (en) | 2010-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202532A2 (hu) | Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása | |
| WO2002010217A2 (en) | Endothelial cell expression patterns | |
| IL130036A (en) | Sarbivine polypeptides, nucleic acids encode the polypeptides and their utilization | |
| EP1991691B1 (en) | Detection of anthrax pathogenicity factors | |
| CN109053883B (zh) | Ns1蛋白的结合蛋白 | |
| Gorasia et al. | Protein interactome analysis of the type IX secretion system identifies PorW as the missing link between the PorK/N ring complex and the Sov translocon | |
| MX2011003634A (es) | Composiciones y metodos para la deteccion de anticuerpos especificos de anaplasma phagocytophilum (aph) y anaplasma platys (apl). | |
| CA2499926A1 (en) | Antibody against von willebrand factor cleaving enzyme and assay system using the same | |
| AU2002258543A1 (en) | Endothelial cell expression patterns | |
| Kulkarni et al. | Single domain antibodies targeting receptor binding pockets of Nada restrain adhesion of neisseria meningitidis to human brain microvascular endothelial cells | |
| CN114349855A (zh) | 新型冠状病毒Delta突变株特异性抗体及其应用 | |
| DK1541676T3 (da) | Mod prothrombin-fragment F1 2 rettede abtistoffer, deres fremstilling og anvendelse | |
| KR20100139096A (ko) | 조성물, 방법 및 키트 | |
| NZ511623A (en) | Methods of identifying antigen gene sequences from Mycoplasma | |
| Pacholczyk et al. | Epitope and mimotope for an antibody to the Na, K‐ATPase | |
| CA2571673A1 (en) | Novel methods of diagnosis of treatment of p. aeruginosa infection and reagents therefor | |
| JP2003130880A (ja) | 異常型プリオン免疫測定用試薬及びキット並びにそれを用いた異常型プリオンの免疫測定方法 | |
| WO2003070768A3 (en) | Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof | |
| JP2005029558A (ja) | エキノコックス症（多包虫症）検査用抗原 | |
| WO2011040429A1 (ja) | ヒトhig1ポリペプチドに対するモノクローナル抗体 | |
| DK1299727T3 (da) | Hidtil ukendt tumorantigen, der er egnet til diagnosticering og behandling af blære-, ovarie-, lunge-, og nyrecancertyper | |
| US20090068218A1 (en) | Antigens for Vaccination Against and Detection of Mycoplasma Suis | |
| US7052860B2 (en) | Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases | |
| JP6502854B2 (ja) | ポリユビキチン化基質の同定方法 | |
| CA2634638C (en) | A bioassay and peptides for use therein |